Cardiol Therapeutics (CRDL) Free Cash Flow (2020 - 2026)
Cardiol Therapeutics (CRDL) posted Free Cash Flow of -$5.4 million for Q1 2026, down 44.11% on a QoQ basis from -$3.8 million in Q4 2025, and down 9.44% year-over-year from -$6.0 million in Q1 2025.
Cardiol Therapeutics (CRDL) Free Cash Flow (2020 - 2026) Analysis & Trends
Cardiol Therapeutics' Free Cash Flow history runs 7 years deep, the most recent figure standing at -$5.4 million for Q1 2026.
- Quarterly Free Cash Flow fell 9.44% year-over-year to -$5.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$17.5 million (up 3.57% YoY) and the FY2025 annual result came in at -$17.1 million, up 4.63% from the prior year.
- Free Cash Flow was -$5.4 million for Q1 2026 at Cardiol Therapeutics, down from -$3.8 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$1.3 million in Q3 2022 and bottomed at -$9.3 million in Q4 2022.
- A 5-year average of -$4.7 million and a median of -$4.8 million in 2023 frame the typical range for Free Cash Flow.
- Peak annual rise in Free Cash Flow reached 74.57% in 2022, while the deepest fall reached 191.99% in 2022.
- Cardiol Therapeutics' Free Cash Flow stood at -$9.3 million in 2022, then jumped by 48.1% to -$4.8 million in 2023, then increased by 16.65% to -$4.0 million in 2024, then rose by 6.21% to -$3.8 million in 2025, then slumped by 44.11% to -$5.4 million in 2026.
- Business Quant data shows CRDL's Free Cash Flow at -$5.4 million in Q1 2026, -$3.8 million in Q4 2025, and -$5.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -208.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 291.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -373.37 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 363.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 348.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 144.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -38.00 Mn |
| 10 | Cardiol Therapeutics | 134.05 Mn | 134.05 Mn | - | -5.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.45 Mn |
| Mar 31, 2026 | -5.45 Mn |
| Dec 31, 2025 | -3.78 Mn |
| Dec 31, 2025 | -3.78 Mn |
| Sep 30, 2025 | -5.03 Mn |
| Sep 30, 2025 | -5.03 Mn |
| Jun 30, 2025 | -3.28 Mn |
| Jun 30, 2025 | -3.28 Mn |
| Mar 31, 2025 | -4.98 Mn |
| Mar 31, 2025 | -4.98 Mn |
| Dec 31, 2024 | -4.03 Mn |
| Dec 31, 2024 | -4.03 Mn |
| Sep 30, 2024 | -5.69 Mn |
| Sep 30, 2024 | -5.69 Mn |
| Jun 30, 2024 | -3.49 Mn |
| Jun 30, 2024 | -3.49 Mn |
| Mar 31, 2024 | -5.13 Mn |
| Mar 31, 2024 | -5.13 Mn |
| Dec 31, 2023 | -4.84 Mn |
| Dec 31, 2023 | -4.84 Mn |